Validate LP for Siemens Advia, Atellica
July 2019—LGC Maine Standards launched its Validate LP linearity and calibration verification kit for Siemens Healthineers Advia and Atellica analyzers.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
EndoPredict IDs chemo benefit in women
July 2019—Myriad Genetics announced a study published in Breast Cancer Research and Treatment found that the EndoPredict test accurately predicts which women with ER-positive, HER2-negative breast cancer will benefit from adjuvant chemotherapy.
Roche, Bio-Techne expand partnership
July 2019—Roche is expanding its partnership with Bio-Techne by offering chromogenic detection kits for automated in situ hybridization tissue analysis.
Magnolia, Center for Phlebotomy Education expand CE program
July 2019—Magnolia Medical Technologies and the Center for Phlebotomy Education have expanded their training and education partnership with a Web-based continuing education course now available with Professional Acknowledgment for Continuing Education (PACE) credits.
FDA clears Ortho Clinical Vitros XT MicroSlides
June 2019—Ortho Clinical Diagnostics’ Vitros XT MicroSlides have been cleared by the FDA. The product features multitest technology that allows laboratories to run two tests simultaneously on one MicroSlide.
BD Bactec platelet QC media
June 2019—BD announced the worldwide availability of its FDA-cleared and CE-marked BD Bactec platelet quality control media to identify contaminated platelet units. The product can be used for quality control testing of leukocyte-reduced apheresis platelet units: leukocyte-reduced single and a pool of up to six units of leukocyte-reduced whole blood platelet concentrates.
Pembrolizumab plus axitinib approved for RCC
June 2019—The Food and Drug Administration approved pembrolizumab (Keytruda, Merck) plus axitinib for the first-line treatment of patients with advanced renal cell carcinoma. Approval was based on Keynote‑426, a randomized, multicenter, open-label trial conducted in 861 patients who had not received systemic therapy for advanced renal cell carcinoma. Patients were enrolled regardless of PD-L1 tumor expression status.
New data for MDxHealth’s prostate cancer Dx
June 2019—Positive data demonstrating the clinical value of ConfirmMDx and SelectMDx (MDxHealth, Irvine, Calif.) for prostate cancer were presented in two moderated posters at the American Urological Association annual meeting, May 1–6 in Chicago.
FDA clears GenMark Dx BCID panel
June 2019—GenMark Diagnostics received FDA 510(k) clearance for its ePlex Blood Culture Identification Gram-Negative Panel.
PerkinElmer introduces DNA test
June 2019—PerkinElmer, in collaboration with Helix, launched a genetic screening test called GenePrism: Actionable Insights, which analyzes a subset of 59 medically actionable genes, including BRCA1 and BRCA2, identified by the American College of Medical Genetics and Genomics.